Aura Biosciences, Inc.

NasdaqGM:AURA Stock Report

Market Cap: US$420.1m

Aura Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:AURA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 24SellUS$110,663Jill HopkinsIndividual11,822US$9.36
29 Oct 24SellUS$5,938Amy ElazzouziIndividual553US$10.74
29 Oct 24SellUS$98,788Elisabet de los PinosIndividual9,200US$10.74
16 Oct 24SellUS$72,723Mark PlavsicIndividual7,383US$9.85
23 Jan 24SellUS$50,521Julie FederIndividual6,609US$7.64
23 Jan 24SellUS$121,141Elisabet de los PinosIndividual15,853US$7.64

Insider Trading Volume

Insider Buying: AURA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of AURA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders663,8631.33%
VC/PE Firms3,039,8926.09%
General Public8,407,15316.8%
Hedge Funds11,803,99523.6%
Institutions26,036,56352.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.9%
Matrix Capital Management Company, LP
6,922,870US$58.2m0%2.31%
11.6%
Eventide Asset Management, LLC
5,802,682US$48.8m0%0.83%
9.77%
Adage Capital Management, L.P.
4,881,125US$41.1m-0.08%0.07%
6.33%
BlackRock, Inc.
3,160,414US$26.6m5.16%no data
6.09%
Medicxi Ventures (UK) LLP
3,039,892US$25.6m0%5.08%
4.05%
Advent Life Sciences LLP
2,023,857US$17.0m0%100.0%
3.61%
The Vanguard Group, Inc.
1,805,434US$15.2m2.15%no data
3.5%
Lundbeckfonden BioCapital
1,750,108US$14.7m-13.3%0.24%
3.34%
Franklin Resources, Inc.
1,668,960US$14.0m14.8%no data
2.54%
Nantahala Capital Management, LLC
1,270,035US$10.7m0%0.78%
2.27%
Long Focus Capital Management LLC
1,133,546US$9.5m7.22%0.83%
2.02%
Geode Capital Management, LLC
1,008,827US$8.5m4.06%no data
1.51%
State Street Global Advisors, Inc.
754,803US$6.3m3.69%no data
1.34%
Regency Capital Management Inc.
667,311US$5.6m-12.8%2.98%
1.03%
T. Rowe Price Group, Inc.
516,126US$4.3m-10%no data
1.03%
Decheng Capital LLC
515,555US$4.3m0%1.06%
0.83%
Levin Capital Strategies, L.P.
413,635US$3.5m26.3%0.33%
0.73%
Northern Trust Global Investments
364,263US$3.1m24.6%no data
0.59%
Dimensional Fund Advisors LP
292,762US$2.5m16.9%no data
0.57%
David Johnson
285,667US$2.4m0%no data
0.55%
Ensign Peak Advisors, Inc.
272,695US$2.3m8.25%no data
0.36%
Elisabet de los Pinos
179,129US$1.5m5.53%no data
0.33%
Platinum Investment Management Limited
162,358US$1.4m0%0.05%
0.29%
Morgan Stanley, Investment Banking and Brokerage Investments
145,708US$1.2m160%no data
0.28%
Janus Henderson Group plc
139,672US$1.2m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 09:36
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aura Biosciences, Inc. is covered by 6 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Liisa BaykoEvercore ISI
Edward WhiteH.C. Wainwright & Co.
Jonathan WollebenJMP Securities